Posted on Leave a comment

Could GPO Plus (GPOX) be a rising star in the giant health care sector for 2022

Could GPO Plus (GPOX) be a rising star in the giant health care sector for 2022
Health care stocks have underperformed the S&P 500 in 2021, but analysts are optimistic that a handful of top health care names are positioned for a big year in 2022.

Health care stocks have underperformed the S&P 500 in 2021, but analysts are optimistic that a handful of top health care names are positioned for a big year in 2022. Stocks exposed to the ongoing pandemic will experience more tail winds in the next couple of quarters, but the health care industry is expected to continue to normalize. Elective care has returned, high costs associated with COVID-19 patient care have subsided, and pharmaceutical and medical equipment stocks have begun to rebound and so are health care stocks (Source 1).

One small cap Health Care Stock that needs attention is GPO Plus (OTCQB:GPOX). Headquartered in Las Vegas, Nevada, GPOPlus+ (OTC US:GPOX) is a publicly traded company of diversified industry-specific Group Purchasing Organizations (GPOs). As per the company’s website, A Group Purchasing Organization (GPO) is an entity that is created to leverage the purchasing power of a group of businesses (or individuals) to obtain discounts from vendors based on the collective buying power of the GPO members. ​Essentially, GPO’s negotiate discounted rates from vendors and service providers which are then passed on to their members.​ GPO’s negotiate discounted rates from vendors and service providers which are then passed on to their members. The first GPO’s were established in the early 1900’s and were initially setup as buying groups for hospitals and the healthcare industry. (Source 2)

The company had recently announced that Wayne Smeal has joined GPOX as its Chief Operating Officer (COO) and a member of the board of directors. Mr. Smeal began his career working for Fortune 500 companies, including McKesson, Armor Food’s, ConAgra, and Kellogg’s. Leaving the corporate world Mr. Smeal ventured into private companies with more than 30 years in owning, operating, and managing businesses in multiple industries including Health, Beauty, Nutrition, Hemp, & Real Estate as well as franchising. Mr. Smeal has a successful history developing management teams and growing successful companies. (Source 3)

Earlier in Dec, 2021, the company had announced the official launch of AntigenTests.com, a project of HealthGPO. HealthGPO is a Group Purchasing Organization for the Healthcare industry with operations and facilities located throughout the United States. As per the press release, the purpose of AntigenTests.com is to provide HealthGPO Members and Point-of-Care providers with competitive pricing and a reliable supply chain for POC COVID-19 tests. (Source 4).

Click HERE To READ MORE ABOUT GPOX

Trading at mere 54 cents, GPO Plus, Inc. (GPOX) could provide a great opportunity for traders and investors into the GPO Sector. As always, conduct your own due diligence and follow traders vigilance. Other noticeable stocks in the Health Care Sector include RISPR Therapeutics (NASDAQ:CRSP), Vertex Pharmaceuticals (NASDAQ:VRTX), Intuitive Surgical (NASDAQ:ISRG), UnitedHealth Group (NYSE:UNH), and Teladoc Health (NYSE:TDOC).

Source 1 – https://money.usnews.com/investing/stock-market-news/slideshows/best-health-care-stocks-to-buy-this-year

Source 2 – https://gpoplus.com/

Source 3 – https://finance.yahoo.com/news/gpoplus-announces-chief-operating-officer-141500262.html

Source 4 -https://finance.yahoo.com/news/gpoplus-announces-launch-antigentests-com-182000079.html

 

Disclaimer: Neither WallStreetPr.com or its associates accepts responsibility for the adequacy or accuracy of this release. This is a paid advertisement. WallStreetPR is simply distributing content provided to us by Bullzeyemedia LLC and is not responsible for producing this content. WallStreetPR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are commercial advertisements and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available to us by BullzeyeMedia LLC is not intended to be, nor does it constitute investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report, and publication. In no event shall WALLSTREETPR be liable to any member, guest, or third party for any damages of any kind arising out of the use of any content or other material published or made available by WALLSTREETPR ., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters is not intended to be, nor does it constitute investment advice or recommendations. WallStreetPR.com strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, Wallstreetpr.com, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. As part of that content, readers, subscribers, and website viewers are expected to read the full disclaimers and financial disclosures statement that can be found on our website by visiting WallStreetPR.com/Disclaimer. WallStreetPR.com has been compensated $750 for advertisement services on GPOX by a 3rd party BullzeyeMedia LLC. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

Media Contact
Company Name: WallStreetPR
Contact Person: Ash K
Email: Send Email
Phone: 2019725655
Country: United States
Website: https://www.wallstreetpr.com/